Litigation Details for AbbVie Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2023)
✉ Email this page to a colleague
AbbVie Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2023)
| Docket | ⤷ Start Trial | Date Filed | 2023-11-07 |
| Court | District Court, D. Delaware | Date Terminated | 2024-01-02 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 10,881,659; 11,045,470; 11,542,239; 11,690,845 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AbbVie Inc. v. Teva Pharmaceuticals, Inc.
Details for AbbVie Inc. v. Teva Pharmaceuticals, Inc. (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-11-07 | External link to document | |||
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
